544 related articles for article (PubMed ID: 35976645)
21. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.
Furukawa K; Tjan LH; Kurahashi Y; Sutandhio S; Nishimura M; Arii J; Mori Y
JAMA Netw Open; 2022 May; 5(5):e2210780. PubMed ID: 35532938
[TBL] [Abstract][Full Text] [Related]
22. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.
Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F
Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China.
Yang W; Yang S; Wang L; Zhou Y; Xin Y; Li H; Mu W; Wu Q; Xu L; Zhao M; Wang C; Yu K
Virol Sin; 2022 Oct; 37(5):704-715. PubMed ID: 35948265
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
[TBL] [Abstract][Full Text] [Related]
25. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
Filippatos F; Tatsi EB; Dellis C; Koukou DM; Papagiannopoulos C; Margeli A; Siahanidou T; Kanaka-Gantenbein C; Syriopoulou V; Michos A
Epidemiol Infect; 2022 Oct; 150():e177. PubMed ID: 36345855
[TBL] [Abstract][Full Text] [Related]
27. Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort.
Sendi P; Widmer N; Branca M; Thierstein M; Büchi AE; Güntensperger D; Blum MR; Baldan R; Tinguely C; Heg D; Theel ES; Berbari E; Tande AJ; Endimiani A; Gowland P; Niederhauser C;
J Med Virol; 2023 Jul; 95(7):e28904. PubMed ID: 37386901
[TBL] [Abstract][Full Text] [Related]
28. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
[TBL] [Abstract][Full Text] [Related]
30. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
[TBL] [Abstract][Full Text] [Related]
31. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
[TBL] [Abstract][Full Text] [Related]
32. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
[TBL] [Abstract][Full Text] [Related]
33. COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.
Akaishi T; Kushimoto S; Katori Y; Sugawara N; Egusa H; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ohsawa M; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
Tohoku J Exp Med; 2022 Sep; 258(2):103-110. PubMed ID: 36002251
[TBL] [Abstract][Full Text] [Related]
34. Nosocomial SARS-CoV-2 transmission in multi-bedded hospital cubicles over successive pandemic waves: Lower mortality but wider spread with Omicron despite enhanced infection-prevention measures.
Wee LE; Conceicao EP; Aung MK; Aung MO; Yang Y; Arora S; Ko KK; Venkatachalam I
Infect Dis Health; 2023 May; 28(2):81-87. PubMed ID: 37032572
[TBL] [Abstract][Full Text] [Related]
35. Critically ill children with SARS-COV-2 Omicron infection at a national children medical center, Guangdong, China.
Lin F; Jiang DJ; Zhang S; Yang Z; Zeng HS; Liu ZP; Yang LY
BMC Pediatr; 2024 Apr; 24(1):254. PubMed ID: 38622552
[TBL] [Abstract][Full Text] [Related]
36. Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection.
Wee LE; Lim JT; Tay AT; Pang D; Dickens B; Chiew CJ; Ong B; Lye DCB; Tan KB
Clin Microbiol Infect; 2024 Apr; 30(4):531-539. PubMed ID: 38141822
[TBL] [Abstract][Full Text] [Related]
37. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
[TBL] [Abstract][Full Text] [Related]
38. Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.
Ward IL; Bermingham C; Ayoubkhani D; Gethings OJ; Pouwels KB; Yates T; Khunti K; Hippisley-Cox J; Banerjee A; Walker AS; Nafilyan V
BMJ; 2022 Aug; 378():e070695. PubMed ID: 35918098
[TBL] [Abstract][Full Text] [Related]
39. Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection.
Zou J; Xia H; Xie X; Kurhade C; Machado RRG; Weaver SC; Ren P; Shi PY
Nat Commun; 2022 Feb; 13(1):852. PubMed ID: 35140233
[TBL] [Abstract][Full Text] [Related]
40. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
